Literature DB >> 9256314

Hepatitis B and C viruses serology in patients with SLE.

M Abu-Shakra1, S El-Sana, M Margalith, E Sikuler, L Neumann, D Buskila.   

Abstract

Sera of 95 patients with SLE were tested for the presence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C antibodies. The results show that HBsAg was not detected in the sera of all of the SLE patients. Only one patient was confirmed to have anti-HCV antibodies, suggesting that chronic infection with hepatitis B and C is not increased in patients with SLE compared with the general population.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9256314     DOI： 10.1177/096120339700600612

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  9 in total

1.  Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.

Authors:  B S Tzang; T Y Chen; T C Hsu; Y C Liu; G J Tsay
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection.

Authors:  Y-Y Wu; T-C Hsu; T-Y Chen; T-C Liu; G-Y Liu; Y-J Lee; G J Tsay
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

4.  Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection.

Authors:  T-C Hsu; G J Tsay; T-Y Chen; Y-C Liu; B-S Tzang
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

5.  European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Authors:  M Mosca; C Tani; M Aringer; S Bombardieri; D Boumpas; R Brey; R Cervera; A Doria; D Jayne; M A Khamashta; A Kuhn; C Gordon; M Petri; O P Rekvig; M Schneider; Y Sherer; Y Shoenfeld; J S Smolen; R Talarico; A Tincani; R F van Vollenhoven; M M Ward; V P Werth; L Carmona
Journal:  Ann Rheum Dis       Date:  2009-11-05       Impact factor: 19.103

6.  Hepatitis B carrier state among SLE patients: case-control study.

Authors:  Omer Gendelman; Naim Mahroum; Doron Comaneshter; Pnina Rotman-Pikielny; Arnon D Cohen; Howard Amital; Michael Sherf
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Management of hepatitis B reactivation in patients with lupus nephritis.

Authors:  Kai-Chung Tse; Susan Yung; Colin Tang; Terence Pok-Siu Yip; Tak Mao Chan
Journal:  Rheumatol Int       Date:  2009-01-22       Impact factor: 2.631

8.  Hepatitis B Virus Infection Rate and Distribution in Chinese Systemic Lupus Erythematosus Patients.

Authors:  Xumin Chen; Lingyao Hong; Wang Zhang; Meng Yuan; Qiongqiong Yang; Haiping Mao; Wei Chen; Xueqing Yu
Journal:  Med Sci Monit       Date:  2015-07-06

9.  Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection.

Authors:  Hsin-Chien Chen; Chi-Hsiang Chung; Chih-Hung Wang; Jung-Chun Lin; Wei-Kuo Chang; Fu-Huang Lin; Chang-Huei Tsao; Yung-Fu Wu; Wu-Chien Chien
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.